FBP is a mitochondria-targeting selective anticancer agent that induces oxidative stress and mitochondrial (Mitochondrial) dysfunction, leading to apoptosis (Apoptosis). It generates ROS, resulting in DNA double-strand breaks in cancer cells. FBP exhibits cytotoxic effects on cancer cells, with cervical cancer cells being the most sensitive. It is applicable in research for cervical cancer, lung cancer, melanoma, and breast cancer.